HLA-B*15:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B*15:02 negative Chinese.
Christina Sze-Man WongDesmond Yat-Hin YapPatrick IpWilfred Hing-Sang WongGilbert T ChuaChi-Keung YeungHenry Hin Lee ChanJanette S Y KwokPublished in: International journal of dermatology (2021)
HLA-B*15:11 is a potential risk factor of CBZ-induced SCARs in HLA-B*15:02 negative Chinese patients. Further screening of HLA-B*15:11 status in those HLA-B*15:02 negative patients is recommended to avoid undesirable SCARs.